BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2992245)

  • 1. Prostaglandin endoperoxide and thromboxane A2 analogs.
    Wilson NH; Jones RL
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 14():393-425. PubMed ID: 2992245
    [No Abstract]   [Full Text] [Related]  

  • 2. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 3. Aza-substituted omega-side-chain modifications of 7-oxabicyclo[2.2.1]heptane thromboxane A2 receptor antagonists: structure-activity relationships.
    Nakane M; Reid JA; Haslanger MF; Garber DP; Harris DN; Ogletree ML; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():291-3. PubMed ID: 3004140
    [No Abstract]   [Full Text] [Related]  

  • 4. Stable carbocyclic analog of thromboxane A2 as antagonist of prostaglandin receptors.
    Shimizu K; Kohli JD; Goldberg LI; Kittisopikul S; Fried J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():333-6. PubMed ID: 6303072
    [No Abstract]   [Full Text] [Related]  

  • 5. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
    Parise LV; Venton DL; Le Breton GC
    J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses of thromboxane A2 analogs: Thia- and dithiathromboxane A2.
    Hamanaka N; Ohuchida S; Hayashi M
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():319-22. PubMed ID: 6221543
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of stable thromboxane A2 analogs: pinane thromboxane A2 (PTA2) and carbocyclic thromboxane A2 (CTA2).
    Nicolaou KC; Magolda RL
    Methods Enzymol; 1982; 86():400-9. PubMed ID: 7132765
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular and functional evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2.
    Yura T; Fukunaga M; Grygorczyk R; Makita N; Takahashi K; Badr KF
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():237-9. PubMed ID: 7732843
    [No Abstract]   [Full Text] [Related]  

  • 9. Thromboxane A2 receptor antagonists.
    Hall SE
    Med Res Rev; 1991 Sep; 11(5):503-79. PubMed ID: 1834898
    [No Abstract]   [Full Text] [Related]  

  • 10. A structural analog of thromboxane A2.
    Ansell MF; Caton MP; Palfreyman MN; Stuttle KA; Tuffin D; Walker JL
    Adv Prostaglandin Thromboxane Res; 1980; 6():485-7. PubMed ID: 7386282
    [No Abstract]   [Full Text] [Related]  

  • 11. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of thromboxane A2 analogs.
    Nicolaou KC; Magolda RL; Claremon DA
    Adv Prostaglandin Thromboxane Res; 1980; 6():481-3. PubMed ID: 6992537
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of receptors activated by analogues of prostaglandin H2 [proceedings].
    Bennett A; Jarosik C; Wilson DE
    Br J Pharmacol; 1978 Jun; 63(2):358P. PubMed ID: 208705
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
    Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
    J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
    Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G
    Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane synthase inhibition combined with thromboxane receptor blockade: a step forward in antithrombotic strategy?
    Gresele P; Van Houtte E; Arnout J; Deckmyn H; Vermylen J
    Thromb Haemost; 1984 Dec; 52(3):364. PubMed ID: 6099616
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible generation of potent vasocontracting substance from prostaglandin endoperoxide analogs, human platelets mixture.
    Shibata S; Ho WK; Ishida U
    J Pharmacol Exp Ther; 1980 Nov; 215(2):357-62. PubMed ID: 7441499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane A2/endoperoxide receptors mediate cholinergic constriction of rabbit lung microvessels.
    Shirai M; Ninomiya I; Sada K
    J Appl Physiol (1985); 1992 Mar; 72(3):1179-85. PubMed ID: 1533210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the pyrogenic potency of the thromboxane A2-mimetics, SQ26655 and U46619, and thromboxane B2 by intrapreoptic injection in the cat.
    Gollman HM; Rudy TA
    Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):305-8. PubMed ID: 3864207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.